PSB-603
CAS: 1092351-10-4
Ref. 3D-STB35110
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
PSB-603 is a small molecule that inhibits the P2Y receptors, which are involved in signal transduction pathways. It has been shown to induce neuronal death by inhibiting the activation of Epidermal Growth Factor Receptor (EGFR) and downstream signaling pathways. PSB-603 has also been shown to have anticancer activity in prostate cancer cells, as well as other types of cancer cells. PSB-603 inhibits proliferation and induces apoptosis in prostate cancer cells through inhibition of EGFR and cAMP levels. The mechanism of action for this drug is not fully understood, but it is thought that it may block transcription or translation processes.
PSB-603 has also been studied for its potential therapeutic applications in autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and multiple sclerosis. This drug may be used to prevent cartilage degradation by blocking the production of inflammatory cytokines such as TNF-α, IL-1β
Propiedades químicas
Consulta técnica sobre: 3D-STB35110 PSB-603
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
